tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mega Genomics Limited Schedules Board Meeting for Year-End Results

Story Highlights
Mega Genomics Limited Schedules Board Meeting for Year-End Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Mega Genomics Limited ( (HK:6667) ) has shared an announcement.

Mega Genomics Limited has announced that its board of directors will meet on March 31, 2025, to consider and approve the company’s final results for the year ending December 31, 2024. The meeting will also address the recommendation of a final dividend and other business matters, which could impact the company’s financial strategy and shareholder returns.

More about Mega Genomics Limited

Mega Genomics Limited is a company incorporated in the Cayman Islands, operating in the genomics industry. It focuses on providing genomic solutions and services, with a market focus that likely includes healthcare and biotechnology sectors.

YTD Price Performance: -34.88%

Average Trading Volume: 111,123

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$1.63B

Find detailed analytics on 6667 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1